Crossmark

Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy

Crossref DOI link: https://doi.org/10.1007/s00134-018-5068-1

Published Online: 2018-02-02

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamaga, Satoshi

Ohshimo, Shinichiro https://orcid.org/0000-0003-1119-3322
Shime, Nobuaki

Nseir, Saad

Sendid, Boualem

Rouzé, Anahita
License Information

Text and Data Mining valid from 2018-02-02
More Information

Article History

Accepted: 13 January 2018

First Online: 2 February 2018

Compliance with ethical standards

:

: SN: MSD, Ciel Medical (lecture, advisory board), other authors: none.